APO Research

APO RESEARCH · REPORT

Medical Device Software Validation

Selected research

Industry Growth & Trends

Global Medical Device Software Validation Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global Medical Device Software Validation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Medical Device Software Validation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Medical Device Software Validation is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Device Software Validation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Medical Device Software Validation market include QbD Group, Intertek, SGS, QuEST, TÜV SÜD AG, NAMSA, Element, Eurofins Scientific and Charles River, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Medical Device Software Validation market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Medical Device Software Validation market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Medical Device Software Validation market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Medical Device Software Validation.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Medical Device Software Validation market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Medical Device Software Validation Market by Company

QbD Group

Intertek

SGS

QuEST

TÜV SÜD AG

NAMSA

Element

Eurofins Scientific

Charles River

Sterling Medical Devices

Pacific Biolabs

Toxikon

Steris Laboratories

Europlaz Technologies

Tata Elxsi

Onyx Healthcare

Medical Device Software Validation Segment by Type

Unit Testing

Integration Testing

System Testing

Others

Medical Device Software Validation Segment by Application

Medical Device Manufacturing

Pharmaceutical

Biotechnology

Research and Development

Medical Device Software Validation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Device Software Validation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Device Software Validation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Device Software Validation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Medical Device Software Validation companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Medical Device Software Validation Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Medical Device Software Validation Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Medical Device Software Validation Market Share by Region (2021-2026) Table 4. Global Medical Device Software Validation Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Medical Device Software Validation Market Share by Region (2027-2032) Table 6. Global Medical Device Software Validation Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Medical Device Software Validation Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Medical Device Software Validation Market Size Share by Type (2021-2026) Table 9. Global Medical Device Software Validation Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Medical Device Software Validation Market Size Share Forecasted by Type (2027-2032) Table 11. North America Medical Device Software Validation Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Medical Device Software Validation Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Medical Device Software Validation Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Medical Device Software Validation Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Medical Device Software Validation Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Medical Device Software Validation Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Medical Device Software Validation Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Medical Device Software Validation Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Medical Device Software Validation Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Medical Device Software Validation Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Medical Device Software Validation Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Medical Device Software Validation Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Medical Device Software Validation Market Size Share by Application (2021-2026) Table 24. Global Medical Device Software Validation Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Medical Device Software Validation Market Size Share Forecasted by Application (2027-2032) Table 26. North America Medical Device Software Validation Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Medical Device Software Validation Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Medical Device Software Validation Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Medical Device Software Validation Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Medical Device Software Validation Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Medical Device Software Validation Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Medical Device Software Validation Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Medical Device Software Validation Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Medical Device Software Validation Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Medical Device Software Validation Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Medical Device Software Validation Industry Trends Table 37. Medical Device Software Validation Industry Drivers Table 38. Medical Device Software Validation Industry Opportunities and Challenges Table 39. Medical Device Software Validation Industry Restraints Table 40. Global Medical Device Software Validation Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Medical Device Software Validation Revenue Market Share by Company (2021-2026) Table 42. Global Medical Device Software Validation Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Medical Device Software Validation Key Company Headquarters & Area Served Table 44. Global Medical Device Software Validation Company, Product Type & Application Table 45. Global Medical Device Software Validation Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Medical Device Software Validation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. QbD Group Company Information Table 49. QbD Group Business Overview Table 50. QbD Group Medical Device Software Validation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. QbD Group Medical Device Software Validation Product Portfolio Table 52. QbD Group Recent Development Table 53. Intertek Company Information Table 54. Intertek Business Overview Table 55. Intertek Medical Device Software Validation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Intertek Medical Device Software Validation Product Portfolio Table 57. Intertek Recent Development Table 58. SGS Company Information Table 59. SGS Business Overview Table 60. SGS Medical Device Software Validation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. SGS Medical Device Software Validation Product Portfolio Table 62. SGS Recent Development Table 63. QuEST Company Information Table 64. QuEST Business Overview Table 65. QuEST Medical Device Software Validation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. QuEST Medical Device Software Validation Product Portfolio Table 67. QuEST Recent Development Table 68. TÜV SÜD AG Company Information Table 69. TÜV SÜD AG Business Overview Table 70. TÜV SÜD AG Medical Device Software Validation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. TÜV SÜD AG Medical Device Software Validation Product Portfolio Table 72. TÜV SÜD AG Recent Development Table 73. NAMSA Company Information Table 74. NAMSA Business Overview Table 75. NAMSA Medical Device Software Validation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. NAMSA Medical Device Software Validation Product Portfolio Table 77. NAMSA Recent Development Table 78. Element Company Information Table 79. Element Business Overview Table 80. Element Medical Device Software Validation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Element Medical Device Software Validation Product Portfolio Table 82. Element Recent Development Table 83. Eurofins Scientific Company Information Table 84. Eurofins Scientific Business Overview Table 85. Eurofins Scientific Medical Device Software Validation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Eurofins Scientific Medical Device Software Validation Product Portfolio Table 87. Eurofins Scientific Recent Development Table 88. Charles River Company Information Table 89. Charles River Business Overview Table 90. Charles River Medical Device Software Validation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Charles River Medical Device Software Validation Product Portfolio Table 92. Charles River Recent Development Table 93. Sterling Medical Devices Company Information Table 94. Sterling Medical Devices Business Overview Table 95. Sterling Medical Devices Medical Device Software Validation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Sterling Medical Devices Medical Device Software Validation Product Portfolio Table 97. Sterling Medical Devices Recent Development Table 98. Pacific Biolabs Company Information Table 99. Pacific Biolabs Business Overview Table 100. Pacific Biolabs Medical Device Software Validation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Pacific Biolabs Medical Device Software Validation Product Portfolio Table 102. Pacific Biolabs Recent Development Table 103. Toxikon Company Information Table 104. Toxikon Business Overview Table 105. Toxikon Medical Device Software Validation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Toxikon Medical Device Software Validation Product Portfolio Table 107. Toxikon Recent Development Table 108. Steris Laboratories Company Information Table 109. Steris Laboratories Business Overview Table 110. Steris Laboratories Medical Device Software Validation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Steris Laboratories Medical Device Software Validation Product Portfolio Table 112. Steris Laboratories Recent Development Table 113. Europlaz Technologies Company Information Table 114. Europlaz Technologies Business Overview Table 115. Europlaz Technologies Medical Device Software Validation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Europlaz Technologies Medical Device Software Validation Product Portfolio Table 117. Europlaz Technologies Recent Development Table 118. Tata Elxsi Company Information Table 119. Tata Elxsi Business Overview Table 120. Tata Elxsi Medical Device Software Validation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Tata Elxsi Medical Device Software Validation Product Portfolio Table 122. Tata Elxsi Recent Development Table 123. Onyx Healthcare Company Information Table 124. Onyx Healthcare Business Overview Table 125. Onyx Healthcare Medical Device Software Validation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Onyx Healthcare Medical Device Software Validation Product Portfolio Table 127. Onyx Healthcare Recent Development Table 128. North America Medical Device Software Validation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Medical Device Software Validation Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Medical Device Software Validation Market Share by Country (2021-2026) Table 131. North America Medical Device Software Validation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Medical Device Software Validation Market Share Forecast by Country (2027-2032) Table 133. Europe Medical Device Software Validation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Medical Device Software Validation Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Medical Device Software Validation Market Share by Country (2021-2026) Table 136. Europe Medical Device Software Validation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Medical Device Software Validation Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Medical Device Software Validation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Medical Device Software Validation Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Medical Device Software Validation Market Share by Country (2021-2026) Table 141. Asia-Pacific Medical Device Software Validation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Medical Device Software Validation Market Share Forecast by Country (2027-2032) Table 143. Latin America Medical Device Software Validation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Medical Device Software Validation Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Medical Device Software Validation Market Share by Country (2021-2026) Table 146. Latin America Medical Device Software Validation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Medical Device Software Validation Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Medical Device Software Validation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Medical Device Software Validation Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Medical Device Software Validation Market Share by Country (2021-2026) Table 151. Middle East & Africa Medical Device Software Validation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Medical Device Software Validation Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Medical Device Software Validation Product Image Figure 3. Global Medical Device Software Validation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Medical Device Software Validation Market Size (2021-2032) & (US$ Million) Figure 5. Global Medical Device Software Validation Market Share by Region: 2025 VS 2032 Figure 6. Global Medical Device Software Validation Market Share by Region (2021-2032) Figure 7. North America Medical Device Software Validation Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Medical Device Software Validation Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Medical Device Software Validation Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Medical Device Software Validation Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Medical Device Software Validation Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Unit Testing Image Figure 13. Global Unit Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Integration Testing Image Figure 15. Global Integration Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. System Testing Image Figure 17. Global System Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Medical Device Software Validation Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Medical Device Software Validation Market Share by Type 2025 VS 2032 Figure 22. North America Medical Device Software Validation Market Size Share by Type (2021-2032) Figure 23. Europe Medical Device Software Validation Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Medical Device Software Validation Market Size Share by Type (2021-2032) Figure 25. Latin America Medical Device Software Validation Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Medical Device Software Validation Market Size Share by Type (2021-2032) Figure 27. Medical Device Manufacturing Image Figure 28. Global Medical Device Manufacturing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Pharmaceutical Image Figure 30. Global Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Biotechnology Image Figure 32. Global Biotechnology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Research and Development Image Figure 34. Global Research and Development Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Medical Device Software Validation Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Medical Device Software Validation Market Share by Application 2025 VS 2032 Figure 37. North America Medical Device Software Validation Market Size Share by Application (2021-2032) Figure 38. Europe Medical Device Software Validation Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Medical Device Software Validation Market Size Share by Application (2021-2032) Figure 40. Latin America Medical Device Software Validation Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Medical Device Software Validation Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Medical Device Software Validation Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Medical Device Software Validation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Medical Device Software Validation Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Medical Device Software Validation Market Share by Country (2021-2032) Figure 47. Europe Medical Device Software Validation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Medical Device Software Validation Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Medical Device Software Validation Market Share by Country (2021-2032) Figure 50. Asia-Pacific Medical Device Software Validation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Medical Device Software Validation Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Medical Device Software Validation Market Share by Country (2021-2032) Figure 53. Latin America Medical Device Software Validation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Medical Device Software Validation Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Medical Device Software Validation Market Share by Country (2021-2032) Figure 56. Middle East & Africa Medical Device Software Validation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Medical Device Software Validation Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Medical Device Software Validation Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Unit Testing
  • Integration Testing
  • System Testing
  • Others
Applications
  • Medical Device Manufacturing
  • Pharmaceutical
  • Biotechnology
  • Research and Development
Companies covered
  • QbD Group
  • Intertek
  • SGS
  • QuEST
  • TÜV SÜD AG
  • NAMSA
  • Element
  • Eurofins Scientific
  • Charles River
  • Sterling Medical Devices
  • Pacific Biolabs
  • Toxikon
  • Steris Laboratories
  • Europlaz Technologies
  • Tata Elxsi
  • Onyx Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Medical Device Software Validation Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Medical Device Software Validation Market Size by Region (2021-2032)
  5. 1.4.1 Global Medical Device Software Validation Market Size by Region (2021-2026)
  6. 1.4.2 Global Medical Device Software Validation Market Size by Region (2027-2032)
  7. 1.5 Key Regions Medical Device Software Validation Market Size (2021-2032)
  8. 1.5.1 North America Medical Device Software Validation Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Medical Device Software Validation Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Medical Device Software Validation Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Medical Device Software Validation Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Medical Device Software Validation Market Size Growth Rate (2021-2032)
2 Medical Device Software Validation Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Unit Testing
  3. 2.1.2 Integration Testing
  4. 2.1.3 System Testing
  5. 2.1.4 Others
  6. 2.2 Global Medical Device Software Validation Market Size by Type
  7. 2.2.1 Global Medical Device Software Validation Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Medical Device Software Validation Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Medical Device Software Validation Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Medical Device Software Validation Market Size by Regions
  11. 2.3.1 North America Medical Device Software Validation Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Medical Device Software Validation Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Medical Device Software Validation Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Medical Device Software Validation Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Medical Device Software Validation Market Size Breakdown by Type (2021-2026)
3 Medical Device Software Validation Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Medical Device Manufacturing
  3. 3.1.2 Pharmaceutical
  4. 3.1.3 Biotechnology
  5. 3.1.4 Research and Development
  6. 3.2 Global Medical Device Software Validation Market Size by Application
  7. 3.2.1 Global Medical Device Software Validation Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Medical Device Software Validation Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Medical Device Software Validation Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Medical Device Software Validation Market Size by Regions
  11. 3.3.1 North America Medical Device Software Validation Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Medical Device Software Validation Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Medical Device Software Validation Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Medical Device Software Validation Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Medical Device Software Validation Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Medical Device Software Validation Industry Trends
  2. 4.2 Medical Device Software Validation Industry Drivers
  3. 4.3 Medical Device Software Validation Industry Opportunities and Challenges
  4. 4.4 Medical Device Software Validation Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Medical Device Software Validation Revenue (2021-2026)
  2. 5.2 Global Medical Device Software Validation Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Medical Device Software Validation Key Company Headquarters & Area Served
  4. 5.4 Global Medical Device Software Validation Company, Product Type & Application
  5. 5.5 Global Medical Device Software Validation Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Medical Device Software Validation Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Medical Device Software Validation Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Medical Device Software Validation Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 QbD Group
  2. 6.1.1 QbD Group Company Information
  3. 6.1.2 QbD Group Business Overview
  4. 6.1.3 QbD Group Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 QbD Group Medical Device Software Validation Product Portfolio
  6. 6.1.5 QbD Group Recent Developments
  7. 6.2 Intertek
  8. 6.2.1 Intertek Company Information
  9. 6.2.2 Intertek Business Overview
  10. 6.2.3 Intertek Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Intertek Medical Device Software Validation Product Portfolio
  12. 6.2.5 Intertek Recent Developments
  13. 6.3 SGS
  14. 6.3.1 SGS Company Information
  15. 6.3.2 SGS Business Overview
  16. 6.3.3 SGS Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 SGS Medical Device Software Validation Product Portfolio
  18. 6.3.5 SGS Recent Developments
  19. 6.4 QuEST
  20. 6.4.1 QuEST Company Information
  21. 6.4.2 QuEST Business Overview
  22. 6.4.3 QuEST Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 QuEST Medical Device Software Validation Product Portfolio
  24. 6.4.5 QuEST Recent Developments
  25. 6.5 TÜV SÜD AG
  26. 6.5.1 TÜV SÜD AG Company Information
  27. 6.5.2 TÜV SÜD AG Business Overview
  28. 6.5.3 TÜV SÜD AG Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 TÜV SÜD AG Medical Device Software Validation Product Portfolio
  30. 6.5.5 TÜV SÜD AG Recent Developments
  31. 6.6 NAMSA
  32. 6.6.1 NAMSA Company Information
  33. 6.6.2 NAMSA Business Overview
  34. 6.6.3 NAMSA Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 NAMSA Medical Device Software Validation Product Portfolio
  36. 6.6.5 NAMSA Recent Developments
  37. 6.7 Element
  38. 6.7.1 Element Company Information
  39. 6.7.2 Element Business Overview
  40. 6.7.3 Element Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Element Medical Device Software Validation Product Portfolio
  42. 6.7.5 Element Recent Developments
  43. 6.8 Eurofins Scientific
  44. 6.8.1 Eurofins Scientific Company Information
  45. 6.8.2 Eurofins Scientific Business Overview
  46. 6.8.3 Eurofins Scientific Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Eurofins Scientific Medical Device Software Validation Product Portfolio
  48. 6.8.5 Eurofins Scientific Recent Developments
  49. 6.9 Charles River
  50. 6.9.1 Charles River Company Information
  51. 6.9.2 Charles River Business Overview
  52. 6.9.3 Charles River Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Charles River Medical Device Software Validation Product Portfolio
  54. 6.9.5 Charles River Recent Developments
  55. 6.10 Sterling Medical Devices
  56. 6.10.1 Sterling Medical Devices Company Information
  57. 6.10.2 Sterling Medical Devices Business Overview
  58. 6.10.3 Sterling Medical Devices Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Sterling Medical Devices Medical Device Software Validation Product Portfolio
  60. 6.10.5 Sterling Medical Devices Recent Developments
  61. 6.11 Pacific Biolabs
  62. 6.11.1 Pacific Biolabs Company Information
  63. 6.11.2 Pacific Biolabs Business Overview
  64. 6.11.3 Pacific Biolabs Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Pacific Biolabs Medical Device Software Validation Product Portfolio
  66. 6.11.5 Pacific Biolabs Recent Developments
  67. 6.12 Toxikon
  68. 6.12.1 Toxikon Company Information
  69. 6.12.2 Toxikon Business Overview
  70. 6.12.3 Toxikon Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Toxikon Medical Device Software Validation Product Portfolio
  72. 6.12.5 Toxikon Recent Developments
  73. 6.13 Steris Laboratories
  74. 6.13.1 Steris Laboratories Company Information
  75. 6.13.2 Steris Laboratories Business Overview
  76. 6.13.3 Steris Laboratories Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Steris Laboratories Medical Device Software Validation Product Portfolio
  78. 6.13.5 Steris Laboratories Recent Developments
  79. 6.14 Europlaz Technologies
  80. 6.14.1 Europlaz Technologies Company Information
  81. 6.14.2 Europlaz Technologies Business Overview
  82. 6.14.3 Europlaz Technologies Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Europlaz Technologies Medical Device Software Validation Product Portfolio
  84. 6.14.5 Europlaz Technologies Recent Developments
  85. 6.15 Tata Elxsi
  86. 6.15.1 Tata Elxsi Company Information
  87. 6.15.2 Tata Elxsi Business Overview
  88. 6.15.3 Tata Elxsi Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Tata Elxsi Medical Device Software Validation Product Portfolio
  90. 6.15.5 Tata Elxsi Recent Developments
  91. 6.16 Onyx Healthcare
  92. 6.16.1 Onyx Healthcare Company Information
  93. 6.16.2 Onyx Healthcare Business Overview
  94. 6.16.3 Onyx Healthcare Medical Device Software Validation Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Onyx Healthcare Medical Device Software Validation Product Portfolio
  96. 6.16.5 Onyx Healthcare Recent Developments
7 North America
  1. 7.1 North America Medical Device Software Validation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Medical Device Software Validation Market Size by Country (2021-2026)
  3. 7.3 North America Medical Device Software Validation Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Medical Device Software Validation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Medical Device Software Validation Market Size by Country (2021-2026)
  3. 8.3 Europe Medical Device Software Validation Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Medical Device Software Validation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Medical Device Software Validation Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Medical Device Software Validation Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Medical Device Software Validation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Medical Device Software Validation Market Size by Country (2021-2026)
  3. 10.3 South America Medical Device Software Validation Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Medical Device Software Validation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Medical Device Software Validation Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Medical Device Software Validation Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research